W. K. Leung

Vonoprazan Dual or Triple Therapy Versus Bismuth-Quadruple Therapy as First-Line Therapy for Helicobacter pylori Infection: A Three-Arm, Randomized Clinical Trial.

Li Ni, Zijie Deng, H. Ng, 2024, Helicobacter.